What is the current Immuno Oncology Assays Kit market size?

The current Immuno Oncology Assays Kit market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Immuno Oncology Assays Kit market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing cancer cases.

What are the key drivers of the Immuno Oncology Assays Kit market?

Key drivers include rising demand for personalized medicine and increasing adoption of immuno-oncology therapies.

What are the major challenges facing the Immuno Oncology Assays Kit market?

Major challenges include high development costs and stringent regulatory requirements.

Which regions are expected to lead the Immuno Oncology Assays Kit market?

North America and Europe are expected to lead the market due to high healthcare expenditure.

Who are the top companies in the Immuno Oncology Assays Kit market?

Top companies include Roche, Merck, and Thermo Fisher Scientific, offering a range of immuno-oncology assays.

What future opportunities exist in the Immuno Oncology Assays Kit market?

Future opportunities include the development of biomarker-based assays and increasing adoption in emerging markets.

How will technology impact the Immuno Oncology Assays Kit market?

Advances in technology, such as next-generation sequencing, will drive growth and innovation in the market.

What is the current regulatory landscape for the Immuno Oncology Assays Kit market?

The regulatory landscape is stringent, with FDA and CE markings required for market approval and commercialization.

What is the future outlook for the Immuno Oncology Assays Kit market?

The future outlook is promising, with increasing demand for immuno-oncology therapies driving market growth.

Immuno Oncology Assays Kit Value Chain Analysis & Forecast Outlook 2033

Immuno Oncology Assays Kit by Application (Research, Clinical Diagnostics), by Types (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $3578 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $3578 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Immuno Oncology Assays Kit Market Size | CAGR 6.8% Forecast 2033

Immuno Oncology Assays Kit Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $3578 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $3578 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Immuno Oncology Assays Kit Market Overview

The Immuno Oncology Assays Kit market is a crucial segment of the healthcare industry, focused on the development and distribution of diagnostic kits for immuno-oncology research. As the global Immuno Oncology Assays Kit market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a promising industry expansion driven by increasing demand for cancer treatments and diagnostics. The scope of this market encompasses various types of assays, including ELISA, flow cytometry, and PCR, catering to applications in research institutions, pharmaceutical companies, and hospitals. With a current market size of approximately $943 million in 2025, the Immuno Oncology Assays Kit market is poised for significant growth, driven by a compound annual growth rate (CAGR) of 10.3% during the forecast period from 2026 to 2033.

Loading chart…

The Immuno Oncology Assays Kit market is shaped by several key forces, including technology shifts towards more sensitive and specific diagnostic techniques, regulations governing the approval and commercialization of diagnostic kits, and competitive intensity among market players. The largest region in the Immuno Oncology Assays Kit market is North America, while the fastest-growing region is expected to be the Asia-Pacific, driven by increasing investments in healthcare infrastructure and research initiatives. As the market continues to evolve, consumer behavior and supply-chain dynamics will play critical roles in determining the success of industry participants. With the global Immuno Oncology Assays Kit market poised for significant growth, industry stakeholders must stay informed about the latest trends, challenges, and opportunities to remain competitive and drive industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	3.58 billion
Revenue forecast in 2033	6.24 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Roche Diagnostics; Agilent Technologies; Illumina; PerkinElmer; Reaction Biology; Bio-Techne
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Immuno Oncology Assays Kit market is poised for significant growth, driven by key factors that are reshaping the industry landscape. Understanding these dynamics is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Advancements in immunotherapy and the increasing adoption of precision medicine are driving the demand for Immuno Oncology Assays Kits, contributing to the growth forecast of the Immuno Oncology Assays Kit market size.

Government initiatives and funding for cancer research are bolstering the development of new immuno-oncology therapies, thereby boosting the Immuno Oncology Assays Kit market.

Restraints2 items

High development costs and the complexity of immuno-oncology assays are significant restraints, potentially slowing the growth of the Immuno Oncology Assays Kit market size and impacting the overall growth forecast.

Stringent regulatory requirements and the need for extensive clinical validation of immuno-oncology assays kits can hinder the market growth, affecting the Immuno Oncology Assays Kit market dynamics.

Opportunities2 items

The increasing prevalence of cancer and the growing demand for personalized medicine present opportunities for the development of innovative immuno-oncology assays, contributing to the expansion of the Immuno Oncology Assays Kit market.

Emerging markets and the growing interest in liquid biopsies offer untapped opportunities for manufacturers of Immuno Oncology Assays Kits, further enhancing the growth forecast of the Immuno Oncology Assays Kit market size.

Challenges2 items

The competitive landscape of the Immuno Oncology Assays Kit market, with numerous players, poses a challenge for new entrants and smaller companies aiming to gain market share and influence the Immuno Oncology Assays Kit market dynamics.

Ensuring the sensitivity and specificity of immuno-oncology assays while maintaining cost-effectiveness is a significant challenge that manufacturers must address to support the growth forecast and Immuno Oncology Assays Kit market size.

Market Segmentation

Loading chart…

The Immuno Oncology Assays Kit market can be segmented based on Application, which includes research and diagnostic applications. The research applications segment holds a significant share of the market, driven by the increasing adoption of immuno-oncology assays in cancer research. The diagnostic applications segment is also expected to grow, driven by the increasing demand for accurate and reliable diagnostic tests for cancer. The Immuno Oncology Assays Kit segmentation by application provides valuable insights into the market, enabling stakeholders to understand the trends and opportunities in each segment.

The Types segment of the Immuno Oncology Assays Kit market includes ELISA, PCR, and Next-Generation Sequencing (NGS) among others. ELISA is a widely used assay type, accounting for a significant share of the market. PCR and NGS are also gaining popularity, driven by their high sensitivity and specificity. The market taxonomy of Immuno Oncology Assays Kit types provides a comprehensive understanding of the market, enabling stakeholders to identify opportunities and challenges in each segment. The types segment is expected to drive the growth of the market, with the increasing adoption of advanced technologies in cancer research and diagnosis.

Immuno Oncology Assays Kit Segmentation Breakdown8 items

Application

Research

Clinical Diagnostics

Types

Immunoassay

Flow Cytometry

PCR

Next Generation Sequencing

Regional Insights

Loading chart…

The Immuno Oncology Assays Kit market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of immuno-oncology therapies and growing investments in healthcare infrastructure.

Key drivers for North America include policies supporting cancer research, a mature ecosystem of pharmaceutical companies, and high demographics of cancer patients. In Europe, drivers include infrastructure development, adoption of innovative technologies, and a strong regulatory framework. Asia Pacific is driven by investments in research and development, growing awareness of cancer treatments, and increasing access to healthcare services.

Latin America and Middle East & Africa are expected to contribute smaller shares to the Immuno Oncology Assays Kit market growth, with key drivers including government initiatives to improve healthcare services, growing partnerships between local and international companies, and increasing demand for cancer treatments. The regional forecast indicates a positive outlook for the global Immuno Oncology Assays Kit market, with opportunities for growth and expansion in various regions.

Competitive Landscape

The Immuno Oncology Assays Kit market is moderately consolidated, with a mix of global players and local companies competing for market share. The Immuno Oncology Assays Kit competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players dominate the market, but local companies are also making inroads through strategic partnerships and regional expansion.

Companies in this market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are focusing on the following strategies:

Thermo Fisher Scientific: regional expansion

Roche Diagnostics: premium pricing

Agilent Technologies: innovation pipeline

Illumina: OEM tie-ups

PerkinElmer: local manufacturing

Reaction Biology: vertical integration

Key Immuno Oncology Assays Kit Companies7 items

Thermo Fisher Scientific

Roche Diagnostics

Agilent Technologies

Illumina

PerkinElmer

Reaction Biology

Bio-Techne

Market Ecosystem

The Immuno Oncology Assays Kit ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers develop and assemble the assays kits; and downstream, where channels and end users interact with the final product. Value is created and captured at each stage, with technology providers and suppliers influencing the development of assays kits, and end users driving demand.

Raw material/component suppliers — provide essential components

OEMs / manufacturers — develop and assemble assays kits

Technology providers — offer underlying technologies and platforms

System integrators / EPCs — integrate assays kits into larger systems

Distributors / channel partners — connect manufacturers with end users

Regulators/standards bodies — establish and enforce industry standards

End users / buyers — drive demand and adoption of assays kits

In the Immuno Oncology Assays Kit ecosystem, control points are primarily held by regulators and standards bodies, as well as large manufacturers and technology providers. Dependency risks arise from input constraints, such as the availability of raw materials, and standards and approvals, which can impact the development and adoption of assays kits. Switching costs and partnerships can also influence the ecosystem, with companies forming alliances to access new technologies or markets. Additionally, interoperability requirements can pose a challenge, particularly in regions with diverse regulatory frameworks, highlighting the need for a thorough value chain analysis to navigate the complex Immuno Oncology Assays Kit ecosystem.

Recent Industry Insights

The Immuno Oncology Assays Kit industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between major pharmaceutical companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also led to the expansion of product portfolios and the integration of new technologies. Furthermore, several companies have launched new products and technologies, enhancing the accuracy and efficiency of immuno-oncology assays. Regulatory changes have also played a crucial role in shaping the industry, with updated guidelines and approvals influencing the development and commercialization of immuno-oncology assays kits.

Additionally, there has been a shift in consumer and enterprise trends, with a growing focus on personalized medicine and targeted therapies. Funding rounds and expansions have also been notable, with several companies securing significant investments to support the development of innovative immuno-oncology assays kits. These developments are expected to continue driving growth in the Immuno Oncology Assays Kit industry, with ongoing research and advancements in technology poised to shape the future of cancer treatment and diagnosis.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Immuno Oncology Assays Kit market outlook. The market exhibits high attractiveness due to the growing demand for immuno-oncology treatments and the increasing adoption of precision medicine. The competitive intensity is moderate, with key players focusing on innovation and strategic partnerships. The long-term outlook is positive, driven by the rising incidence of cancer and the need for effective treatments.

The innovation landscape is dynamic, with ongoing research and development in areas such as biomarker discovery and companion diagnostics. The demand-supply balance is stable, with manufacturers investing in capacity expansion to meet growing demand. However, key risk factors include regulatory uncertainties and high development costs. Overall, the Immuno Oncology Assays Kit market is poised for sustained growth, driven by advances in immuno-oncology research and the increasing adoption of personalized medicine.

12 items

1. Executive Summary

2. Immuno Oncology Assays Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Immuno Oncology Assays Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Immuno Oncology Assays Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Immuno Oncology Assays Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Immuno Oncology Assays Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Immuno Oncology Assays Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Immuno Oncology Assays Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Immuno Oncology Assays Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Immuno Oncology Assays Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Immuno Oncology Assays Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Immuno Oncology Assays Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Immuno Oncology Assays Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Immuno Oncology Assays Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Immuno Oncology Assays Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Immuno Oncology Assays Kit Market Competition by Key Manufacturers

9.1. Global Immuno Oncology Assays Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Immuno Oncology Assays Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Roche Diagnostics

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Agilent Technologies

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Illumina

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. PerkinElmer

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Reaction Biology

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Bio-Techne

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Immuno Oncology Assays Kit Market

Figure 4: Global Immuno Oncology Assays Kit Market: Drivers

Figure 5: Global Immuno Oncology Assays Kit Market: Challenges

Figure 6: Global Immuno Oncology Assays Kit Market: Trends

Figure 7: Global Immuno Oncology Assays Kit Market: Opportunity

Figure 8: Global Immuno Oncology Assays Kit Market: Restraint

Figure 9: Global Immuno Oncology Assays Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Immuno Oncology Assays Kit Market Value (USD Million) By Region

Figure 19: Global Immuno Oncology Assays Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Immuno Oncology Assays Kit Market Value (USD Million) By Region

Figure 27: Global Immuno Oncology Assays Kit Market Share (%) By: Regions (2032)

Figure 28: Global Immuno Oncology Assays Kit Market Volume (K) By Region

Figure 29: Global Immuno Oncology Assays Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Immuno Oncology Assays Kit Market Value (USD Million) By Region

Figure 37: Global Immuno Oncology Assays Kit Market Share (%) By: Regions (2032)

Figure 38: Global Immuno Oncology Assays Kit Market Volume (K) By Region

Figure 39: Global Immuno Oncology Assays Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Immuno Oncology Assays Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Immuno Oncology Assays Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Immuno Oncology Assays Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Immuno Oncology Assays Kit Market Value (USD Million) By Region

Table 14: Global Immuno Oncology Assays Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Immuno Oncology Assays Kit Market Volume (K) By Region

Table 31: Global Immuno Oncology Assays Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Immuno Oncology Assays Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Immuno Oncology Assays Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Immuno Oncology Assays Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Scientific Basic Information And Sales Area

Table 52: Thermo Fisher Scientific. Products Portfolio

Table 53: Roche Diagnostics Basic Information And Sales Area

Table 54: Roche Diagnostics. Products Portfolio

Table 55: Agilent Technologies Basic Information And Sales Area

Table 56: Agilent Technologies. Products Portfolio

Table 57: Illumina Basic Information And Sales Area

Table 58: Illumina. Products Portfolio

Table 59: PerkinElmer Basic Information And Sales Area

Table 60: PerkinElmer. Products Portfolio

Table 61: Reaction Biology Basic Information And Sales Area

Table 62: Reaction Biology. Products Portfolio

Table 63: Bio-Techne Basic Information And Sales Area

Table 64: Bio-Techne. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Immuno Oncology Assays Kit Market Value (USD Million) By Region

Table 74: Global Immuno Oncology Assays Kit Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Immuno Oncology Assays Kit Market Volume (K) By Region

Table 91: Global Immuno Oncology Assays Kit Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Immuno Oncology Assays Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	3.58 billion
Revenue forecast in 2033	6.24 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Roche Diagnostics; Agilent Technologies; Illumina; PerkinElmer; Reaction Biology; Bio-Techne
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options